SHIFT AI Newsroom · GLOBAL
Research Explores Opposite Approaches to Obesity Treatment
A study published on PubMed examines the efficacy and tolerability of GIPR agonism and antagonism in obesity pharmacotherapy.
Researchers are exploring two opposite approaches to treating obesity: GIPR agonism and antagonism. A study published on PubMed examines the efficacy and tolerability of these approaches in obesity pharmacotherapy.
What this means in the UK
This research may have implications for the development of new treatments for obesity in the UK.
Known facts
- GIPR agonism and antagonism are being researched as potential treatments for obesity.